Učitavanje...
Evaluating the administration costs of biologic drugs: development of a cost algorithm
Biologic drugs, as with all other medical technologies, are subject to a number of regulatory, marketing, reimbursement (financing) and other demand-restricting hurdles applied by healthcare payers. One example is the routine use of cost-effectiveness analyses or health technology assessments to det...
Spremljeno u:
| Izdano u: | Health Econ Rev |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883988/ https://ncbi.nlm.nih.gov/pubmed/26208926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13561-014-0026-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|